1.
Review article: the epidemiology and prevention of gastric cancer
by Fock, K. M.
Alimentary pharmacology & therapeutics, 2014, Vol.40 (3), p.250-260
2.
The challenge of screening for early gastric cancer in China
by Zong, Liang
The Lancet (British edition), 2016, Vol.388 (10060), p.2606-2606
3.
Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled...
by Fukase, Kazutoshi, MD
The Lancet (British edition), 2008, Vol.372 (9636), p.392-397
4.
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
by Malfertheiner, Peter
Gut, 2012, Vol.61 (5), p.646-664
5.
Screening of gastric cancer in Asia
by Sugano, Kentaro, MD, Professor Emeritus
Baillière's best practice & research. Clinical gastroenterology, 2015, Vol.29 (6), p.895-905
6.
The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention
by Lee, Yi-Chia
Gut, 2013, Vol.62 (5), p.676-682
7.
The fight against gastric cancer – the IARC Working Group report
by Herrero, Rolando, MD, PhD
Baillière's best practice & research. Clinical gastroenterology, 2014, Vol.28 (6), p.1107-1114
8.
Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research
by Fitzgerald, Rebecca C
Journal of medical genetics, 2010, Vol.47 (7), p.436-444
9.
Long noncoding RNA LINC00675 enhances phosphorylation of vimentin on Ser83 to suppress gastric cancer progression
by Zeng, Shuo
Cancer letters, 2018, Vol.412, p.179-187
10.
Body mass index, height and risk of adenocarcinoma of the oesophagus and gastric cardia: a prospective cohort study
by Merry, Audrey H H
Gut, 2007, Vol.56 (11), p.1503-1511
11.
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report
by Malfertheiner, P
Gut, 2007, Vol.56 (6), p.772-781
12.
13.
Roadmap to eliminate gastric cancer with Helicobacter pylori eradication and consecutive surveillance in Japan
by Asaka, Masahiro
Journal of gastroenterology, 2013, Vol.49 (1), p.1-8
14.
Genome-Wide Association Studies and Aggressive Surgery Toward Individualized Prevention, and Improved Local Control and Overall Survival for Gastric Cancer
by Roukos, Dimitrios H
Annals of surgical oncology, 2009, Vol.16 (4), p.795-798
15.
Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions
by Wong, Benjamin C Y
Gut, 2012, Vol.61 (6), p.812-818
16.
Seventeen-year effects of eradicating Helicobacter pylori on the prevention of gastric cancer in patients with peptic ulcer; a prospective cohort study
by Take, Susumu
Journal of gastroenterology, 2014, Vol.50 (6), p.638-644
17.
Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication
by Leung, W K
Gut, 2004, Vol.53 (9), p.1244-1249
18.
The changing epidemiology of Asian digestive cancers: From etiologies and incidences to preventive strategies
by Wu, Chun-Ying, MD, PhD, MPH
Baillière's best practice & research. Clinical gastroenterology, 2015, Vol.29 (6), p.843-853
19.
Helicobacter pylori virulence factors in gastric carcinogenesis
by Wen, Sicheng
Cancer letters, 2008, Vol.282 (1), p.1-8
20.
Epidemiology of gastric cancer in Japan
by Inoue, M
Postgraduate Medical Journal, 2005, Vol.81 (957), p.419-424
